Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification

Journal of Cellular Biochemistry

Volumn 116, Issue 10, 2015, Pages 2354-2364

  Li, Xin ^a   Lim, Jina ^a   Lu, Jinxiu ^b   Pedego, Taylor M ^a   Demer, Linda ^a,b,c   Tintut, Yin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

Author keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION; TNF ; TUMOR NECROSIS FACTOR ; VALVULAR CELLS

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; SMAD6 PROTEIN; SMAD7 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BMP2 PROTEIN, MOUSE; SMAD6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; ASCENDING AORTA; CALCIFIC AORTIC VASCULAR AND VALVULAR DISEASE; CALCIFICATION; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HYPERLIPIDEMIA; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VALVULAR HEART DISEASE; ANIMAL; AORTA; AORTA VALVE STENOSIS; BIOSYNTHESIS; CALCINOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; LENTIVIRINAE; METABOLISM; PATHOLOGY;

MURINAE; MUS;

ALKALINE PHOSPHATASE; ANIMALS; AORTA; AORTIC VALVE; AORTIC VALVE STENOSIS; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LENTIVIRUS; MICE; OSTEOBLASTS; SIGNAL TRANSDUCTION; SMAD6 PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939130806     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25186     Document Type: Article

References (38)

1. -/- mice. Arterioscler Thromb Vasc Biol 27: 2589-2596.
2. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL,. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91: 1800-1809.
3. Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK,. 2000. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 121: 255-260.
4. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS,. 2007. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49: 1860-1870.
5. Buendia P, Montes de Oca A, Madueno JA, Merino A, Martin-Malo A, Aljama P, Ramirez R, Rodriguez M, Carracedo J,. 2014. 2014. Endothelial microparticles mediate inflammation-induced vascular calcification. FASEB J 21: 173-81.
6. Chen JH, Sone ED, Yip CY,. 2009. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 174: 1109-1119.
7. Cheng SL, Behrmann A, Shao JS, Ramachandran B, Krchma K, Bello Arredondo Y, Kovacs A, Mead M, Maxson R, Towler DA,. 2014. Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets. Diabetes 63: 4326-4337.
8. Cote N, Mahmut A, Bosse Y, Couture C, Page S, Trahan S, Boulanger MC, Fournier D, Pibarot P, Mathieu P,. 2013. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 36: 573-581.
9. Demer LL,. 1991. Effect of calcification on in vivo mechanical response of rabbit arteries to balloon dilation. Circulation 83: 2083-2093.
10. Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, Zapol WM, Bloch KD, Yu PB,. 2012. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol 32: 613-622.
11. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ,. 2001. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21: 1998-2003.
12. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T,. 2006. Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281: 27229-27241.
13. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA, Jr., Falb D, Huszar D,. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24: 171-174.
14. Glesne D, Huberman E,. 2006. Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation. Oncogene 25: 4086-4098.
15. Gondrie MJ, van der Graaf Y, Jacobs PC, Oen AL, Mali WP,. 2011. The association of incidentally detected heart valve calcification with future cardiovascular events. Eur Radiol 21: 963-973.
16. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR,. 1994. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9: 855-863.
17. Huang MS, Sage AP, Lu J, Demer LL, Tintut Y,. 2008. Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun 374: 553-558.
18. Kaden JJ, Kilic R, Sarikoc A, Hagl S, Lang S, Hoffmann U, Brueckmann M, Borggrefe M,. 2005. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med 16: 869-872.
19. Lai CF, Shao JS, Behrmann A, Krchma K, Cheng SL,. 2012. TNFR1-Activated Reactive Oxidative Species Signals Up-Regulate Osteogenic Msx2 Programs in Aortic Myofibroblasts. Endocrinology 153: 3897-3910.
20. Lee HL, Woo KM, Ryoo HM,. 2010. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun 391: 1087-1092.
21. London GM, Marchais SJ, Guerin AP, Metivier F,. 2002. Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. Nephrol Dial Transplant 17 (Suppl 11): 13-15.
22. Ma L, Lu MF, Schwartz RJ, Martin JF,. 2005. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611.
23. Mandal CC, Ganapathy S, Gorin Y, Mahadev K, Block K, Abboud HE, Harris SE, Ghosh-Choudhury G, Ghosh-Choudhury N,. 2011. Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Biochem J 433: 393-402.
24. Mohler 3rd ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH,. 1999. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8: 254-260.
25. Mohler 3rd ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS,. 2001. Bone formation and inflammation in cardiac valves. Circulation 103: 1522-1528.
26. Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H,. 2010. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol 30: 1908-1915.
27. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL, Jr., Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM, Jr., Kaul S, Wolk MJ,. 2000. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 102: 126-140.
28. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL,. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680-687.
29. Pirih F, Lu J, Ye F, Bezouglaia O, Atti E, Ascenzi MG, Tetradis S, Demer L, Aghaloo T, Tintut Y,. 2012. Adverse effects of hyperlipidemia on bone regeneration and strength. J Bone Miner Res 27: 309-318.
30. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA,. 2009. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 5: 185-197.
31. Shao JS, Cheng SL, Sadhu J, Towler DA,. 2010. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55: 579-592.
32. Song R, Fullerton DA, Ao L, Zheng D, Zhao KS, Meng X,. 2015. BMP-2 and TGF-beta1 mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells. J Mol Med (Berl) 93: 403-412.
33. Swierszcz J, Dubiel JS, Krzysiek J, Sztefko K,. 2011. One-year observation of inflammatory markers in patients with aortic valve stenosis. J Heart Valve Dis 20: 639-649.
34. Tintut Y, Parhami F, Bostrom K, Jackson SM, Demer LL,. 1998. CAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273: 7547-7553.
35. Tintut Y, Patel J, Parhami F, Demer LL,. 2000. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102: 2636-2642.
36. Wang Y, Wu B, Chamberlain AA, Lui W, Koirala P, Susztak K, Klein D, Taylor V, Zhou B,. 2013. Endocardial to myocardial notch-wnt-bmp axis regulates early heart valve development. PLoS ONE 8: e60244.
37. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL,. 1994. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93: 2106-2113.
38. Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, Furukawa K,. 2011. Tumor necrosis factor-alpha accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther 337: 16-23.